ModernaTX Inc., Cambridge, Massachusetts, was awarded a $10,500,000 modification (P00023) to contract W911QY-20-C-0100 for a change to the production schedule from one presentation/type of COVID-19 vaccine to a different presentation/type. Work will be performed in Cambridge, Massachusetts, with an estimated completion date of June 30, 2022. Coronavirus Response and Relief Supplemental Appropriations funds in the amount of $10,500,000 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity. (Awarded April 14, 2022)